See more : Checkpoint Therapeutics, Inc. (CKPT) Income Statement Analysis – Financial Results
Complete financial analysis of Sotera Health Company (SHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sotera Health Company, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Thanachart Capital Public Company Limited (TCAP.BK) Income Statement Analysis – Financial Results
- Altharwah Albashariyyah Co. (9606.SR) Income Statement Analysis – Financial Results
- Encompass Holdings, Inc. (ECMH) Income Statement Analysis – Financial Results
- Capital & Regional Plc (CRPLF) Income Statement Analysis – Financial Results
- ARCA biopharma, Inc. (ABIO) Income Statement Analysis – Financial Results
Sotera Health Company (SHC)
About Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.05B | 1.00B | 931.48M | 818.16M | 778.33M | 746.15M |
| Cost of Revenue | 472.13M | 446.68M | 412.81M | 374.59M | 382.90M | 388.90M |
| Gross Profit | 577.16M | 557.00M | 518.67M | 443.57M | 395.43M | 357.25M |
| Gross Profit Ratio | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% | 47.88% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.36M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 236.67M | 245.71M | 198.16M | 178.53M | 147.48M | 133.36M |
| Other Expenses | 63.80M | 62.94M | 63.78M | 59.03M | 58.56M | 3.87M |
| Operating Expenses | 300.47M | 308.65M | 261.94M | 237.55M | 206.04M | 191.34M |
| Cost & Expenses | 772.60M | 755.34M | 674.75M | 612.14M | 588.94M | 580.24M |
| Interest Income | 0.00 | 80.14M | 74.19M | 215.26M | 157.73M | 0.00 |
| Interest Expense | 142.88M | 80.14M | 74.19M | 215.26M | 157.73M | 143.33M |
| Depreciation & Amortization | 160.34M | 147.75M | 153.15M | 145.51M | 148.77M | 148.15M |
| EBITDA | 420.20M | -2.99M | 404.25M | 319.96M | 305.25M | 316.60M |
| EBITDA Ratio | 40.05% | 31.66% | 36.04% | 33.55% | 44.11% | 42.43% |
| Operating Income | 276.69M | 248.35M | 256.73M | 206.02M | 183.60M | 80.85M |
| Operating Income Ratio | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% | 10.84% |
| Total Other Income/Expenses | -170.67M | -491.46M | -81.02M | -244.88M | -184.51M | -56.63M |
| Income Before Tax | 106.03M | -243.11M | 175.72M | -38.86M | -916.00K | 24.22M |
| Income Before Tax Ratio | 10.10% | -24.22% | 18.86% | -4.75% | -0.12% | 3.25% |
| Income Tax Expense | 54.65M | -9.54M | 58.60M | -1.37M | 19.51M | 30.10M |
| Net Income | 51.38M | -233.57M | 116.88M | -37.49M | -20.43M | -5.87M |
| Net Income Ratio | 4.90% | -23.27% | 12.55% | -4.58% | -2.62% | -0.79% |
| EPS | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| EPS Diluted | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
| Weighted Avg Shares Out | 281.01M | 280.10M | 279.23M | 283.25M | 284.42M | 246.15M |
| Weighted Avg Shares Out (Dil) | 283.22M | 280.10M | 279.38M | 283.25M | 284.42M | 246.15M |
Sotera Health to Share Next Chapter of Growth at 2024 Investor Day
CLEVELAND, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, will hold an Investor Day in New York City...
Sotera Health Company (SHC) Q3 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Sean...
Sotera Health (SHC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Sotera Health (SHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street...
Sotera Health Company (SHC) Q3 Earnings Lag Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.21 per share a year ago.
Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results
CLEVELAND, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for...
Analysts Estimate Sotera Health Company (SHC) to Report a Decline in Earnings: What to Look Out for
Sotera Health (SHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sotera Health Announces Dates for Third-Quarter 2024 Earnings Release and November 2024 Investor Day
CLEVELAND, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results...
Sotera Health Announces Secondary Offering of Common Stock
CLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are...
Sotera Health Company (SHC) Q2 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q2 2024 Earnings Conference Call August 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Dave...
Compared to Estimates, Sotera Health (SHC) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago...
Source: https://incomestatements.info
Category: Stock Reports